-

Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley.

Please note, at the time it releases its fourth quarter and year-end 2025 financial results, the Company's previously announced name change to Chiron Real Estate Inc. will have taken effect.

Webcast Information

Participants may access the call via live webcast by visiting the “Investor Relations” section of the Company's new website at www.chironre.com/investor/investor-overview/default.aspx. The Company encourages use of the webcast due to potential extended wait times to access the conference call via dial-in.

Conference Call

For those unable to access the webcast, participants from within the U.S. should dial 1-877-704-4453, and participants from outside the U.S. should dial 1-201-389-0920.

Replay Information

A replay of the call will be available from approximately 12:00 p.m. Eastern Time on February 26, 2026, through 11:59 p.m. Eastern Time on March 12, 2026. To access the replay, the domestic dial-in number is 1-844-512-2921, the international dial-in number is 1-412-317-6671, and the passcode is 13758015. The archive of the webcast will be available on the Company's website for a limited time.

About Global Medical REIT Inc.

Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com. Beginning on February 23, 2026, the Company’s new website will be www.chironre.com

Contacts

Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869

Global Medical REIT Inc.

NYSE:GMRE

Release Versions

Contacts

Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869

More News From Global Medical REIT Inc.

Chiron Real Estate Inc. Completes Acquisition of Inaugural SHOP Communities

BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), announced today that it has completed the previously announced acquisition of The Landing (the “Landing”) and The Riviera (the “Riviera”), two premier senior living communities located in the Washington, DC MSA, from affiliates of Silverstone Senior Living (“Silverstone”) for an aggregate purchase price of $249 million. “Crossing the finish line on this transaction represents a significant milestone...

Chiron Real Estate Inc. Announces Appointment of Charles Fitzgerald to its Board of Directors and the Declaration of its Second Quarter Preferred Dividends

BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the appointment of Charles Fitzgerald to the Company’s Board of Directors (the “Board”), effective as of May 20, 2026, and the declaration of the Company’s second quarter 2026 preferred dividends. Mr. Fitzgerald will serve as a member of the Board’s Compensation and Nominating and Corporate Governance Committees. Underscoring his strong alignment with shareholder interests, Mr. Fitzg...

Chiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment Led by Maewyn Capital Partners

BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the entry into an agreement providing for up to a $100 million delayed-draw convertible perpetual preferred equity investment led by Maewyn Capital Partners (“Maewyn”). “This growth equity investment represents an important milestone in the repositioning of Chiron. Maewyn’s capital provides long-term flexibility and is expected to accelerate our transition toward higher-return opport...
Back to Newsroom